Dual Protein Inhibition Reverses Lung Scarring in Preclinical Study
In a groundbreaking development poised to transform the therapeutic landscape for idiopathic pulmonary fibrosis (IPF), researchers at Virginia Tech’s Fralin ...
In a groundbreaking development poised to transform the therapeutic landscape for idiopathic pulmonary fibrosis (IPF), researchers at Virginia Tech’s Fralin ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine